Iteos Therapeutics, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
iTeos Therapeutics' 10-K filing summarizes the company's financial results for 2024 and highlights the clinical progress of its immuno-oncology programs.
iTeos Therapeutics' 2023 10-K filing details the company's financial status, clinical trial advancements, and strategic collaborations in the immuno-oncology space.